Ledger.Open graph →

SEC Form D · filed April 22, 2025

NurExone Biologic Inc

Offering

$3.8M

Sold

$1.6M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

TECHNION CITY, HAIFA, L3

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Oded Orgil · Technion City, Haifa, L3Director Yoram Drucker · Technion City, Haifa, L3Exec Lior Shaltiel · Technion City, Haifa, L3Exec · Director Gadi Riesenfeld · Technion City, Haifa, L3Director James Richardson · Technion City, Haifa, L3Director Eran Ovadya · Technion City, Haifa, L3Exec Oded Orgil · Technion City, Haifa, L3Director Gadi Riesenfeld · Technion City, Haifa, L3Director Lior Shaltiel · Technion City, Haifa, L3Exec · Director Eran Ovadya · Technion City, Haifa, L3Exec Yoram Drucker · Technion City, Haifa, L3Exec James Richardson · Technion City, Haifa, L3Director Aaron Wallace · Phoenix, AZExec Sean E. Foster · San Juan, Puerto RicoExec · Director Weston Reynolds · New York, NYExec Gregory L. White · Winchester, VADirector David Cohen · Phoenix, AZDirector Byron Marchant · Phoenix, AZDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗